• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 22 of 100
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By Arthur Allen and KFF Health NewsApril 13, 2023
A zombie apocalypse isn’t likely–but a fungal outbreak is
Commentary
A zombie apocalypse isn’t likely–but a fungal outbreak is
By David AnguloApril 11, 2023
Saundra Pelletier, CEO of Evofem Biosciences.
Newsletters
U.S. women need better birth control. So why is this contraceptive company ‘on life support?’
By Maria Aspan and Kinsey CrowleyApril 5, 2023
A 79-year-old ‘white collar drug dealer’ who sold opioids to pharmacies is going to serve only 2 years in prison
Health
A 79-year-old ‘white collar drug dealer’ who sold opioids to pharmacies is going to serve only 2 years in prison
By Bob Van Voris and BloombergMarch 8, 2023
photo of an "EpiPen" box
Health
After capping the price of insulin, Colorado sets its sights on EpiPen copays
By Helen Santoro and Kaiser Health NewsFebruary 27, 2023
Mark Cuban has been taking on the drug industry. But which one?
Health
Mark Cuban has been taking on the drug industry. But which one?
By Darius Tahir and Kaiser Health NewsFebruary 17, 2023
FDA Commissioner Robert Califf
Health
The first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
By Matthew Perrone and The Associated PressJanuary 6, 2023
FDA headquarters
Health
Alzheimer’s drug approval by FDA ‘rife with irregularities,’ Congress finds after 18-month investigation
By The Associated PressDecember 30, 2022
ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
Health
ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
By Matthew Perrone and The Associated PressDecember 18, 2022
COVID, burnout, and drug shortages: Children and parents are paying the price for the medical system’s dysfunction
Commentary
COVID, burnout, and drug shortages: Children and parents are paying the price for the medical system’s dysfunction
By Ellen DaSilvaDecember 15, 2022
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune
Health
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune
By Arthur Allen and Kaiser Health NewsNovember 8, 2022
Birth control pills
Health
U.S. considering its very first over-the-counter birth control pill: Here’s who’s on board and who isn’t
By Sophie MellorOctober 4, 2022
Yes, there’s an Adderall shortage. Experts say high demand and the pandemic are fueling it
Health
Yes, there’s an Adderall shortage. Experts say high demand and the pandemic are fueling it
By Erin PraterSeptember 30, 2022
Joe Biden in front of an American flag.
Finance
Biden’s new executive order triggers new front in U.S.-China economic competition
By Tristan BoveSeptember 12, 2022
Portrait of GoodRx CEO Doug Hirsch.
Leadership
The CEO of GoodRx doesn’t think mail order pharmacies are the ‘right answer’ to lowering prescription drug prices
By Paolo ConfinoSeptember 2, 2022
1...
  • 20
  • 21
  • 22
  • 23
  • 24
...100
Most Popular
Arts & Entertainment
Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine commentsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 18, 2026
C-Suite
Meet Warren Buffett's son Howard, a former sheriff, war photographer, and now, Berkshire's new chairmanplaceholder alt text
By Catherina GioinoSeptember 18, 2026
Success
Anthropic billionaire cofounder Jack Clark studied literature, not code—and says liberal arts degrees will win in the AI ageplaceholder alt text
By Marco Quiroz-GutierrezSeptember 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.